Dow Chemical forecast better-than-expected revenue for the current quarter and said it would expand four key consumer businesses, which will be part of a new firm created after its proposed merger with DuPont.
Dow and DuPont plan to merge and then break up into three independent publicly traded companies, with the first spinoff being called “Material Science”.
Dow will expand in the packaging, infrastructure, transportation and consumer care markets, Chief Executive Officer Andrew Liveris said on a post-earning call on Thursday, adding that 90 percent of the Material Science company’s revenue would be “aligned” to these end-markets.
DuPont said on Tuesday it expected its deal with Dow to close in August, after repeated delays due to strict regulatory scrutiny.
The merger was approved by EU antitrust regulators last month on the condition the companies divest assets and research and development facilities.
Regulators in the United States, Brazil, China, Australia and Canada are yet to clear the deal.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas